Exhibit 107
Calculation of Filing Fee Tables
FORM 424(b)(5)
(Form Type)
Arrowhead Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee(1) | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||||
Fees to Be Paid | Equity | Common stock, par value $0.001 share | Rule 457(r) | 15,790,000 | $28.50 | $450,015,000 | 0.0001476 | $66,422.22 | ||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||
Carry Forward Securities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||||||||||
Total Offering Amounts | $450,015,000 | $66,422.22 | ||||||||||||||||||||||||||
Total Fees Previously Paid | - | |||||||||||||||||||||||||||
Total Fee Offsets | - | |||||||||||||||||||||||||||
Net Fee Due | $66,422.22 |
(1) | The registration fee is calculated in accordance with Rule 457(r) of the Securities Act and represents deferred payment of the registration fees in connection with the Registrant’s registration statement on Form S-3ASR (Registration No. 333-268665) paid with the filing of this prospectus supplement. |